These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2946966)

  • 21. Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysis.
    Zemel D; Struijk DG; Dinkla C; Stolk LM; ten Berge IJ; Krediet RT
    J Lab Clin Med; 1995 Aug; 126(2):204-15. PubMed ID: 7636393
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression and release of interleukin-8 by peritoneal macrophages and polymorphonuclear leukocytes during peritonitis in uremic patients on continuous ambulatory peritoneal dialysis.
    Lin CY; Huang TP
    Nephron; 1994; 68(4):437-41. PubMed ID: 7870228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Properties of human peritoneal macrophages from continuous ambulatory peritoneal dialysis (CAPD) patients.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    FEMS Microbiol Immunol; 1989 Apr; 1(5):303-4. PubMed ID: 2631872
    [No Abstract]   [Full Text] [Related]  

  • 24. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship.
    Carozzi S; Nasini MG; Ravera M; Sanna A; Tirotta A; Lamperi S
    Adv Perit Dial; 1997; 13():7-12. PubMed ID: 9360642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis.
    Fieren MW; van den Bemd GJ; Bonta IL
    Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients.
    Carozzi S; Nasini MG; Schelotto C; Caviglia PM; Canepa M; Zanin T; Cantaluppi A; Salit M
    Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bactericidal activity of peritoneal macrophages from continuous ambulatory dialysis patients.
    McGregor SJ; Brock JH; Briggs JD; Junor BJ
    Nephrol Dial Transplant; 1987; 2(2):104-8. PubMed ID: 3112647
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.
    Lai KN; Lai KB; Lam CW; Chan TM; Li FK; Leung JC
    Am J Kidney Dis; 2000 Apr; 35(4):644-52. PubMed ID: 10739785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis.
    Carozzi S; Salit M; Cantaluppi A; Nasini MG; Barocci S; Cantarella S; Lamperi S
    J Clin Microbiol; 1989 Aug; 27(8):1748-53. PubMed ID: 2504774
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fas expression on peritoneal macrophages during continuous ambulatory peritoneal dialysis peritonitis.
    Chen CY; Wu CY; Tsai TC; Lin WT; Lee WJ; Su CC; Chen HC; Chiang HC
    Ren Fail; 2008; 30(3):297-301. PubMed ID: 18350449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages.
    Fieren MW; van den Bemd GJ; Ben-Efraim S; Bonta IL
    Immunol Lett; 1992 Jan; 31(1):85-90. PubMed ID: 1548034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytokine-induced peritoneal fibrosis in CAPD. Effects of Ca++ and 1,25(OH)2D3.
    Carozzi S; Nasini MG; Caviglia PM; Schelotto C; Santoni O; Barocci S; Versace F; Cantaluppi A; Salit M; Lamperi S
    ASAIO Trans; 1989; 35(3):418-20. PubMed ID: 2512968
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific opsonic activity for staphylococci in peritoneal dialysis effluent during continuous ambulatory peritoneal dialysis.
    Nielsen H; Espersen F; Kharazmi A; Antonsen S; Ejlersen E; Joffe P; Pedersen FB
    Am J Kidney Dis; 1992 Oct; 20(4):372-5. PubMed ID: 1415206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Peritoneal membrane defence mechanism in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    Contrib Nephrol; 1987; 57():69-78. PubMed ID: 3315441
    [No Abstract]   [Full Text] [Related]  

  • 35. Neutrophil function in patients on continuous ambulatory peritoneal dialysis.
    Harvey DM; Sheppard KJ; Morgan AG; Fletcher J
    Br J Haematol; 1988 Mar; 68(3):273-8. PubMed ID: 3355789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are intracellularly penetrating antibiotics warranted in CAPD-related peritonitis?
    de Fijter CW; Verbrugh HA; Heezius HC; van Bronswijk H; van der Meulen J; Oe PL; Donker AJ; Verhoef J
    Adv Perit Dial; 1989; 5():124-7. PubMed ID: 2577393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis.
    Fieren MW
    Blood Purif; 1996; 14(2):179-87. PubMed ID: 8785034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lympho-monokine disorders and peritoneal fibroblast proliferation in CAPD.
    Lamperi S; Carozzi S; Nasini MG
    ASAIO Trans; 1986; 32(1):35-8. PubMed ID: 3096356
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of peritoneal white blood cell parameters from continuous ambulatory peritoneal dialysis patients with a high or low incidence of peritonitis.
    Holmes CJ; Lewis SL; Kubey WY; Van Epps DE
    Am J Kidney Dis; 1990 Mar; 15(3):258-64. PubMed ID: 2154926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diversity in peritoneal macrophage response of CAPD patients to 1,25-dihydroxyvitamin D3.
    Levy R; Klein J; Rubinek T; Alkan M; Shany S; Chaimovitz C
    Kidney Int; 1990 May; 37(5):1310-5. PubMed ID: 2161062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.